Literature DB >> 14554243

Chromosome arm 8p and cancer: a fragile hypothesis.

Daniel Birnbaum1, José Adélaïde, Cornel Popovici, Emmanuelle Charafe-Jauffret, Marie-Joelle Mozziconacci, Max Chaffanet.   

Abstract

Chromosome arm 8p is one of the most frequently altered regions in human cancers. Several potential oncogenes and tumour suppressor genes have been identified but further investigations are needed to confirm which are bona fide oncogenic targets. In cancer cells, chromosome breaks may occur at fragile sites throughout the genome. Some fragile sites lie within genes that may have a role in cancer; the best example is FHIT at 3p14, which contains the fragile site FRA3B. We have found that chromosome breaks disrupt the NRG1 gene at 8p12 in breast and pancreatic cancers. We hypothesise that alteration of the NRG1 gene could occur through breakage at a non-common fragile site.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14554243     DOI: 10.1016/s1470-2045(03)01225-7

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  20 in total

1.  Compound haploinsufficiency of Dok2 and Dusp4 promotes lung tumorigenesis.

Authors:  Ming Chen; Jiangwen Zhang; Alice H Berger; Moussa S Diolombi; Christopher Ng; Jacqueline Fung; Roderick T Bronson; Mireia Castillo-Martin; Tin Htwe Thin; Carlos Cordon-Cardo; Robin Plevin; Pier Paolo Pandolfi
Journal:  J Clin Invest       Date:  2018-11-26       Impact factor: 14.808

2.  Zeppo1 is a novel metastasis promoter that represses E-cadherin expression and regulates p120-catenin isoform expression and localization.

Authors:  Euan M Slorach; Jonathan Chou; Zena Werb
Journal:  Genes Dev       Date:  2011-02-11       Impact factor: 11.361

3.  DNA methylation changes in a human cell model of breast cancer progression.

Authors:  Sandra V Fernandez; Kara E Snider; Yue-Zhong Wu; Irma H Russo; Christoph Plass; Jose Russo
Journal:  Mutat Res       Date:  2010-03-01       Impact factor: 2.433

4.  Recurrent and nonrandom DNA copy number and chromosome alterations in Myc transgenic mouse model for hepatocellular carcinogenesis: implications for human disease.

Authors:  Drazen B Zimonjic; Veronika Ullmannova-Benson; Valentina M Factor; Snorri S Thorgeirsson; Nicholas C Popescu
Journal:  Cancer Genet Cytogenet       Date:  2009-05

5.  Integrated Genomic Analysis of Pancreatic Ductal Adenocarcinomas Reveals Genomic Rearrangement Events as Significant Drivers of Disease.

Authors:  Stephen J Murphy; Steven N Hart; Geoffrey C Halling; Sarah H Johnson; James B Smadbeck; Travis Drucker; Joema Felipe Lima; Fariborz Rakhshan Rohakhtar; Faye R Harris; Farhad Kosari; Subbaya Subramanian; Gloria M Petersen; Timothy D Wiltshire; Benjamin R Kipp; Mark J Truty; Robert R McWilliams; Fergus J Couch; George Vasmatzis
Journal:  Cancer Res       Date:  2015-12-16       Impact factor: 12.701

6.  A cluster of cooperating tumor-suppressor gene candidates in chromosomal deletions.

Authors:  Wen Xue; Thomas Kitzing; Stephanie Roessler; Johannes Zuber; Alexander Krasnitz; Nikolaus Schultz; Kate Revill; Susann Weissmueller; Amy R Rappaport; Janelle Simon; Jack Zhang; Weijun Luo; James Hicks; Lars Zender; Xin Wei Wang; Scott Powers; Michael Wigler; Scott W Lowe
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-07       Impact factor: 11.205

7.  Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays.

Authors:  Meng Chen; Yuanqing Ye; Hushan Yang; Pheroze Tamboli; Surena Matin; Nizar M Tannir; Christopher G Wood; Jian Gu; Xifeng Wu
Journal:  Int J Cancer       Date:  2009-11-15       Impact factor: 7.396

8.  Neuregulin1 acts as a suppressor in human lung adenocarcinoma via AKT and ERK1/2 pathway.

Authors:  Youya Wang; Zhifeng Ning; Xuefeng Zhou; Zetian Yang; Hexiao Tang; Ming Xu; Xianguo Wang; Jinping Zhao; Yuting Bai
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

9.  The NRG1 gene is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor gene.

Authors:  Y L Chua; Y Ito; J C M Pole; S Newman; S-F Chin; R C Stein; I O Ellis; C Caldas; M J O'Hare; A Murrell; P A W Edwards
Journal:  Oncogene       Date:  2009-10-05       Impact factor: 9.867

10.  NRG1 Genetic Variant Influences the Efficacy of Androgen-Deprivation Therapy in Men with Prostate Cancer.

Authors:  Shu-Pin Huang; Yei-Tsung Chen; Lih-Chyang Chen; Cheng-Hsueh Lee; Chao-Yuan Huang; Chia-Cheng Yu; Victor C Lin; Te-Ling Lu; Bo-Ying Bao
Journal:  Biomedicines       Date:  2021-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.